| Expression pattern: |
UP |
| Associated gene: |
PGK1, AGO2 |
| Associated microRNA: |
miR-4458 |
| Biological function: |
promotes cell proliferation, migration, invasion, glycolysis and tumor growth; inhibits apoptosis in breast cancer |
| Molecular mechanism: |
Acts as a miRNA sponge for miR-4458 to upregulate PGK1 expression (ceRNA-like regulation), promoting malignant phenotypes and glycolysis in breast cancer. |
| Biological pathway or process: |
glycolysis (promotes); proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Clinical Sample Validation; Bioinformatics Analysis; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Annexin V/PI Flow Cytometry; Transwell Assay; Wound Healing Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry) |
| Clinical significance: |
circHMCU might be an underlying prognostic biomarker for BC. |
| Description: |
circHMCU (hsa_circ_0000247) is up-regulated in breast cancer tissues and cell lines and acts as an oncogenic circRNA. It sponges miR-4458 to increase PGK1, thereby promoting glycolysis and malignant phenotypes (proliferation, migration/invasion) and suppressing apoptosis, and its knockdown reduces xenograft tumor growth. |
| Confidence score: |
0.8299 |